Found: 6
Select item for more details and to access through your institution.
First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony.
- Published in:
- PLoS Neglected Tropical Diseases, 2009, v. 3, n. 7, p. 1, doi. 10.1371/journal.pntd.0000491
- By:
- Publication type:
- Article
First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony.
- Published in:
- PLoS Neglected Tropical Diseases, 2009, v. 3, n. 7, p. 1, doi. 10.1371/journal.pntd.0000491
- By:
- Publication type:
- Article
Clinical and Parasite Species Risk Factors for Pentavalent Antimoniall Treatment Failure in Cutaneous Leishmaniasis in Peru.
- Published in:
- Clinical Infectious Diseases, 2008, v. 46, n. 2, p. 223, doi. 10.1086/524042
- By:
- Publication type:
- Article
Development of a Genetic Assay to Distinguish between Leishmania viannia Species on the Basis of Isoenzyme Differences.
- Published in:
- Clinical Infectious Diseases, 2006, v. 42, n. 6, p. 801, doi. 10.1086/500326
- By:
- Publication type:
- Article
A Simplified and Standardized Polymerase Chain Reaction Format for the Diagnosis of Leishmaniasis.
- Published in:
- Journal of Infectious Diseases, 2008, v. 198, n. 10, p. 1565, doi. 10.1086/592509
- By:
- Publication type:
- Article
Influence of Leishmania (Viannia) Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis.
- Published in:
- Journal of Infectious Diseases, 2007, v. 195, n. 12, p. 1846, doi. 10.1086/518041
- By:
- Publication type:
- Article